Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CHMP recommends AstraZeneca’s Qtrilmet for type 2 diabetes

pharmaceutical-technologySeptember 25, 2019

Tag: CHMP , AstraZeneca , Qtrilmet , Diabetes , Forxiga

PharmaSources Customer Service